Arkema SA (OTCMKTS:ARKAY) Sees Large Decrease in Short Interest

Arkema SA (OTCMKTS:ARKAYGet Free Report) was the target of a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 1,065 shares, a drop of 16.9% from the December 31st total of 1,282 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 13,698 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 13,698 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on ARKAY shares. Barclays lowered Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 11th. Deutsche Bank Aktiengesellschaft cut shares of Arkema from a “buy” rating to a “hold” rating in a report on Monday, November 24th. Finally, Zacks Research lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce”.

Check Out Our Latest Report on Arkema

Arkema Stock Performance

Shares of ARKAY opened at $62.36 on Wednesday. The firm has a market capitalization of $4.74 billion, a PE ratio of 29.98, a P/E/G ratio of 1.23 and a beta of 0.90. The company has a quick ratio of 2.26, a current ratio of 3.07 and a debt-to-equity ratio of 0.55. The firm has a 50-day moving average price of $60.62 and a 200 day moving average price of $63.87. Arkema has a 52-week low of $56.28 and a 52-week high of $91.51.

Arkema (OTCMKTS:ARKAYGet Free Report) last issued its quarterly earnings results on Friday, November 7th. The basic materials company reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.21. Arkema had a net margin of 1.55% and a return on equity of 5.15%. The company had revenue of $2.52 billion during the quarter, compared to analyst estimates of $2.50 billion. On average, sell-side analysts anticipate that Arkema will post 8.36 earnings per share for the current fiscal year.

Arkema Company Profile

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

See Also

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.